The FDA recently made it known that Xeljanz can cause significant harm if taken in the wrong dosage. Pfizer created the drug in hopes that it would properly treat patients with arthritis, but the frequency and intensity of its side effects have made it unsafe. As Xeljanz sparks litigation, you may be asking yourself if you need a Xeljanz lawyer.
Xeljanz has been produced and distributed as a way to combat psoriatic and rheumatoid arthritis through its active ingredient, tofacitinib. Janus Kinases are enzymes in the human body that can eventually inflame and damage joints. Tofacitinib works to suppress those enzymes and reduce the symptoms of arthritis. Xeljanz isn’t expected to work for about 2 to 8 weeks for most patients., and you’re warned that the full effects of the drug may not take effect for 3 to 6 months.
With taking Xeljanz, there are risks of some uncomfortable side effects. The common ones being:
Personal Injury cases are authenticated on the basis of your diagnosis, prescription, and reaction to the drug. Xeljanz lawsuits are growing as the drug negatively effects more patients. It was created with the intention to treat arthritis, but was soon discovered to cause additional complications. Xeljanz puts you at risk for developing blood clots in your lungs and may eventually lead to death. However, the litigation process isn’t in motion yet, but to qualify you’ll need records of:
It’d be best to contact your pharmacist, doctor, or medical facility for records of this information. If you’re uncomfortable doing so, or prefer legal aid in obtaining these records, please call Sweeney Merrigan law to speak with one of our experienced attorneys.
Sweeney Merrigan Law works around the clock to ensure our clients are comfortable and compensated for what they deserve. If you believe you’re suffering due to someone else’s negligence, and are in need of a Xeljanz lawyer, contact us at (617)-391-9001 for a free consultation.
We use cookies on our site to analyze traffic, enchance your experience, and provide you with tailored content.
For full functionality of this site, you must consent to the use of cookies. For more information or to opt out, visit our privacy policy